TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. - Wikidata - wikimedia - TriplyDB

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

http://www.wikidata.org/entity/Q35837124

about

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes Frequent overexpression of HMGA1 and 2 in gastroenteropancreatic neuroendocrine tumours and its relationship to let-7 downregulation Management of gastric and duodenal neuroendocrine tumors Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review Clinical features of gastroenteropancreatic tumours Neuroendocrine differentiation: The mysterious fellow of colorectal cancer Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management Endoscopic diagnosis and management of type I neuroendocrine tumors PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids Recent developments in imaging of pancreatic neuroendocrine tumors Imaging of gastroenteropancreatic neuroendocrine tumors Neuroendocrine pancreatic tumors: guidelines for management and update Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors Neuroendocrine tumors of the gastro-entero-pancreatic system Streptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms--Predictive and Prognostic Markers for Treatment Stratification Contrast-enhanced ultrasound of pancreatic tumours.Everolimus-based combination for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): biological rationale and critical review of published data.Radiolabeled somatostatin analogues therapy in advanced neuroendocrine tumors: a single centre experience Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network.Non-functioning pancreatic neuroendocrine tumors: Surgery or observation?Neuroendocrine tumors of colon and rectum: validation of clinical and prognostic values of the World Health Organization 2010 grading classifications and European Neuroendocrine Tumor Society staging systems Prognostic factors of long-term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12-year experience from a single center.Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors.Comparison of relapse-free survival in gastric neuroendocrine carcinoma (WHO grade 3) and gastric carcinoma.Insights into gastric neuroendocrine tumors burden Clinical outcomes and prognostic factors of resected pancreatic neuroendocrine neoplasms: A single-center experience in China Prognostic relevance of UCH-L1 and α-internexin in pancreatic neuroendocrine tumors.Hepatobiliary neuroendocrine carcinoma: a case report.Clinicopathological features and surgical outcomes of neuroendocrine tumors of ampulla of Vater Molecular characteristics and predictors of survival in patients with malignant neuroendocrine tumors.Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours.Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.Well-differentiated neuroendocrine tumors: a review covering basic principles to loco-regional and targeted therapies Diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors: current data on a prospectively collected, retrospectively analyzed clinical multicenter investigation.Developing a multivariable prognostic model for pancreatic endocrine tumors using the clinical data warehouse resources of a single institution.Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group.Expression of O(6)-methylguanine DNA methyltransferase (MGMT) and its clinical significance in gastroenteropancreatic neuroendocrine neoplasm Neuroendocrine tumors of the gastrointestinal tract: Case reports and literature review.

P2860

Q24603675-29CD17A1-CED0-4934-B661-E5D5D3FB034D Q24655168-D6EAD08C-7EE4-4A85-9F7B-63947A68389F Q26738541-70ADEC83-2D40-432D-BB3B-F93DC49E3787 Q26768483-4C58D347-4B5F-4E9A-82B7-C0DC2BEEE371 Q26777896-2B09C255-CFE8-4DA9-B889-EFCA4EA3197A Q26778012-34A4FF08-7013-4AE4-BA12-8894E6C1008B Q26795597-F84EB6D6-9FDC-492C-B646-41A7B6CAF809 Q26824302-235942CA-E098-4DC2-90F2-D8E3938D9230 Q26992201-BC2AE5A5-58B1-4D1D-9B2F-D9EAF8A8B5C7 Q26996521-C24C6780-55B3-4251-977E-33CBC64355FA Q27005697-84C56C59-BEC9-4B96-9C9C-90075CB4FAF1 Q28238305-1B01C661-73E8-400E-95D1-D57D5C0449F3 Q28256132-838C4AE9-8139-483B-A865-3CF9179ED2DB Q28285545-76197B34-2610-41E3-87D5-8141D453F348 Q28290833-D4F407DD-1575-4645-BE0F-157252E4ABD8 Q28294432-EC876C3F-595F-4C63-B035-50C5A860B4E7 Q28551275-C714C4A7-0586-4276-8A50-8C9A9306ADBE Q30363460-787B1355-D10C-412F-9B9C-6DBE43EFFE0C Q30884794-E69BCAF0-A012-4E00-9ACA-94693DB30DF9 Q33403035-45557D99-439F-4E0C-B319-D3242F2A433A Q33514751-EC8B84D3-5987-400D-B035-8185C7FD413A Q33573118-AB6ECB31-D1D6-4B12-ACB5-378FDCE25D94 Q33591842-0FDF527F-2165-4F87-B7A2-BF871942AE3C Q33597784-1902F2A4-C13F-4BD1-8886-D9DAEC36BE46 Q33598860-A875CDB2-B948-46F4-913C-36A747A68373 Q33632569-A6891281-E3B0-4922-AC83-B083DA7B509B Q33649959-8C808F86-3B43-44CB-8DE7-F911FCAD6F84 Q33684746-C0840007-8EEE-4F48-B15B-1E42BA582EB1 Q33708663-1209839C-3940-4F02-A53C-98106B2EE7B1 Q33718655-27A2F268-5871-4BBA-9B50-B81A0376306D Q33750527-28FEA732-19DA-4714-9791-B8A7233E7165 Q33775632-6649ECDA-AD8D-4180-AB50-E6505942A648 Q33783119-8F4C7858-C65B-442F-91DC-369785194DF5 Q33823783-654BE8F1-3070-45CD-A9FD-50E494C39CED Q33840177-4FB8D0AD-4ACE-4F1D-9FE6-33455ED3AC73 Q33863393-3B66BCD3-3CE3-4E13-BE25-5284FBD649CE Q33892438-1DC266E0-A457-4CC0-A577-3BC6EBCE5CA6 Q33894587-D809EFC2-061C-47AF-9994-382E1A422A11 Q34029197-A48B5899-57F5-4664-9DA3-D5D507684391 Q34049125-F9BF3EF8-71F8-455A-860D-EF1C0941B019

P2860

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

http://www.wikidata.org/entity/Q35837124

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

TNM staging of foregut (neuro) ...... al including a grading system.

@ast

TNM staging of foregut (neuro) ...... al including a grading system.

@en

type

label

TNM staging of foregut (neuro) ...... al including a grading system.

@ast

TNM staging of foregut (neuro) ...... al including a grading system.

@en

prefLabel

TNM staging of foregut (neuro) ...... al including a grading system.

@ast

TNM staging of foregut (neuro) ...... al including a grading system.

@en

P1433

Q35837124-B09E43BA-18E7-4C3A-AE3C-B43E443A00F2

P1476

Q35837124-26C899E2-8293-4420-A888-A8D4CC1EDC21

P2093

Q35837124-0C8159C3-B12A-4536-8A10-151393591233

Q35837124-1C5B8EEA-C64B-4AC0-A5F2-A48DCBDD25BB

Q35837124-1FB01689-48D4-4ED5-977F-6AFE4BA3AF80

Q35837124-2387E094-F8E7-4590-9681-8BCA1301A2B0

Q35837124-23A96D1D-C094-4E47-8E1A-C552CCD261E9

Q35837124-2CE8BF02-11C4-4E09-AC93-BEE0AAD9B4AF

Q35837124-2D7178AC-05EC-4363-90B7-9EC94D621657

Q35837124-4E9327DC-8FC0-49C2-906C-249E6B4E6896

Q35837124-54079207-5782-4F76-8739-C2C1FCA0AFDC

Q35837124-55A3BD7F-DC12-45AE-A27C-F307D749E1C0

P2860

Q35837124-0460B67B-7407-4A45-9F78-70C853025E50

Q35837124-0480DAB6-44B7-4680-9DC6-E6FFC78F985A

Q35837124-10A4F0CF-0468-4AB7-8378-4882D89EBF44

Q35837124-16028961-157F-4D98-8970-A3A56AD9B10C

Q35837124-172C5248-9413-406B-B796-8B30485A3728

Q35837124-203E5BB3-03BA-4139-8FA8-E451D861A8B8

Q35837124-2D6115CA-4770-4D1D-8A55-2807BD8ABE4C

Q35837124-3C2BF7C5-51BB-4941-93C2-81C394E5C7C9

Q35837124-569868A9-64A2-4C18-99B2-3FD7402731CF

Q35837124-575D3BF0-5310-44A5-BC86-4CD44EA9FDC4

P2888

Q35837124-5BC48920-ACE1-4714-9665-797F6CBDEBDC

P304

Q35837124-9E894799-F553-435C-9638-9A696E8FC4D1

P31

Q35837124-F2C6653B-0FDC-4066-82EE-9AC300D357BD

P356

Q35837124-643D4A05-E0A6-4A18-8197-1F2D22E198A1

P433

Q35837124-403BB8F6-24E6-4B98-B0B2-C966EFFEF0B8

P478

Q35837124-7DD9B2AA-3368-42FB-A51F-8C208047D638

P50

Q35837124-1A5C0A17-CA1A-4C6D-93F6-E66E18627FEC

Q35837124-40232D0E-D3B6-4FDC-8941-56A2C1366674

Q35837124-6C2494E4-3FF2-4CC8-96E1-40173305BC3E

Q35837124-6D6C2F80-4AA5-4749-B759-2B24F8668D62

Q35837124-7E8BE615-C4EB-4D76-A7FE-EEA22990D988

Q35837124-D087E800-926C-4E3B-82E0-2225A13B7BC4

P577

Q35837124-23B3CCB5-7127-4A86-A05D-BEC8256850A1

P5875

Q35837124-7CEF4279-EC16-4901-A6AC-19B8A6220FBE

P698

Q35837124-3B4C9E21-C835-4CDB-B164-2C31A2F8FF5C

P921

Q35837124-21236DC6-A60D-4DF9-9FB3-EA8D188BC76F

Q35837124-B4F09A1C-3E5A-4C3E-9E72-F0AA97E347EA

P932

Q35837124-CC47FB21-7800-41A2-AF60-7190AF36EDA1

P356

S00428-006-0250-1

P1433

Virchows Archiv

P1476

TNM staging of foregut (neuro) ...... sal including a grading system

@en

P2093

A Couvelard

http://www.w3.org/2001/XMLSchema#string

A-M McNicol

http://www.w3.org/2001/XMLSchema#string

B Erikssson

http://www.w3.org/2001/XMLSchema#string

B Wiedenmann

http://www.w3.org/2001/XMLSchema#string

European Neuroendocrine Tumor Society (ENETS)

http://www.w3.org/2001/XMLSchema#string

G Klöppel

http://www.w3.org/2001/XMLSchema#string

H Alhman

http://www.w3.org/2001/XMLSchema#string

J-Y Scoazec

http://www.w3.org/2001/XMLSchema#string

M Caplin

http://www.w3.org/2001/XMLSchema#string

M Körner

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours

Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system

Treatment of metastatic neuroendocrine carcinomas based on WHO classification.

Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors.

Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups.

A 5-decade analysis of 13,715 carcinoid tumors.

Current status of gastrointestinal carcinoids.

Updated population-based review of carcinoid tumors.

Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide.

P2888

s00428-006-0250-1

P304

395-401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00428-006-0250-1

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

449

http://www.w3.org/2001/XMLSchema#string

P50

Massimo Falconi

José Manuel Lopes

Alberto Falchetti

P577

2006-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6824289

http://www.w3.org/2001/XMLSchema#string

P698

16967267

http://www.w3.org/2001/XMLSchema#string

P921

neuroendocrine tumor

gastrointestinal system cancer

P932

1888719

http://www.w3.org/2001/XMLSchema#string